One-stop Patient Support
Chiesi Total CareSM is a comprehensive support program that provides exceptional service for you and your patients. To enroll your patients, fill out the patient enrollment form online or print and fax the completed form to 1-877-914-0591.
A single call to your dedicated Chiesi Total Care team and the completed enrollment form is all it takes to begin the process of getting a patient started on FILSUVEZ® (birch triterpenes) therapy.*
Call toll free:
1-833-670-6464
*Chiesi Total Care provides non-financial assistance to patients with and without prescription drug coverage.
Lesa, Chiesi Total Care Pharmacist
The Chiesi Total Care Program Assists With:
Commercial insurance
If your patients have private insurance through their job or their own business
Government insurance
If your patients have Medicare, Medicaid, Veterans Affairs Healthcare, or other similar government insurance
No insurance
If your patients have no insurance, they may be eligible for additional financial assistance
The dedicated Chiesi Total Care team is made up of:
- Pharmacists
- Patient Service Coordinators
- Reimbursement Support Specialists
- Nursing support
Worry-free refills
A pharmacist is always available and medication is delivered right to your patient’s door
Access and Support Services
Chiesi Total Care will provide information on financial assistance options based on the individualized needs of your patients.
- Financial assistance
- Copay program help
- Patient Assistance Program (PAP)
- Additional financial services may be available for eligible patients
Download a FILSUVEZ Starter Kit today
If you are ready to start a patient on FILSUVEZ, a FILSUVEZ Starter Kit can help streamline the process. The Kit provides you with everything you need to get a patient started on FILSUVEZ including:
Contact Information
Phone
Fax
1-877-914-0591
Hours of operation
Monday to Friday
8:00 AM – 8:00 PM (Eastern Time)
Location
24 Summit Park Drive Pittsburgh, PA 15275
Helpful Links for Your Patients
FILSUVEZ® (birch triterpenes) topical gel
Indication and Important Safety Information
INDICATION
FILSUVEZ is indicated for the treatment of wounds associated with dystrophic and junctional epidermolysis bullosa (EB) in adult and pediatric patients 6 months of age and older.
IMPORTANT SAFETY INFORMATION
Warnings & Precautions
Local hypersensitivity and skin reactions have been reported in patients treated with FILSUVEZ, including urticaria and dermatitis. If signs or symptoms of hypersensitivity occur, discontinue use immediately and initiate appropriate therapy.
Adverse Reactions
The most commonly reported adverse reaction in clinical trials was pruritus and pain at the wound application site (7.3%).
Patient Counseling Information
Please refer to Prescribing Information for administration instructions.
To report SUSPECTED ADVERSE REACTIONS, contact Chiesi USA Inc. at 1-888-9260 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please see full Prescribing Information.
Indication and Important Safety Information
INDICATION
FILSUVEZ is indicated for the treatment of wounds associated with dystrophic and junctional epidermolysis bullosa (EB) in adult and pediatric patients 6 months of age and older.
IMPORTANT SAFETY INFORMATION
Warnings & Precautions
Local hypersensitivity and skin reactions have been reported in patients treated with FILSUVEZ, including urticaria and dermatitis. If signs or symptoms of hypersensitivity occur, discontinue use immediately and initiate appropriate therapy.
Adverse Reactions
The most commonly reported adverse reaction in clinical trials was pruritus and pain at the wound application site (7.3%).
Patient Counseling Information
Please refer to Prescribing Information for administration instructions.
To report SUSPECTED ADVERSE REACTIONS, contact Chiesi USA Inc. at 1-888-9260 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please see full Prescribing Information.